TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Tissium has raised €160M across 4 funding rounds from 10 investors, most recently a round in Jun 2026. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-06-24 | Other | €30M | Cathay,Family Offices,Mérieux Développement | View deal → |
| 2026-06-24 | Debt | €30M | European Investment Bank | View deal → |
| 2023-05-23 | Series D+ | €50M | Cathay Health,Credit Mutuel Innovation,Fonds Stratégique des Transitions,Merieux Developpement,Sofinnova Partners | View deal → |
| 2021-08-31 | Series C | €50M | Cathay Capital,Sofinnova Partners | View deal → |
